Remove companies wedbush-securities-inc
article thumbnail

Why This Twitter Analyst Says Whistleblower A 'Huge Potential Win' For Elon Musk

Benzinga

A former Twitter Inc (NYSE: TWTR ) security chief has turned whistleblower, alleging the company knew of security and bot issues. The information could support Tesla Inc (NASDAQ: TSLA ) CEO Elon Musk’s accusations the social media platform has downplayed bot issues.

98
article thumbnail

Magenta Therapeutics and Dianthus Therapeutics Announce Merger Agreement

Benzinga

May 03, 2023 (GLOBE NEWSWIRE) -- Magenta Therapeutics, Inc. NASDAQ: MGTA ) ("Magenta") and Dianthus Therapeutics, Inc. The combined company will focus on advancing Dianthus' pipeline of next-generation complement inhibitors, including DNTH103 currently in a Phase 1 clinical trial. ET CAMBRIDGE, Mass.,

Finance 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Coherus to Acquire Surface Oncology

Benzinga

June 16, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. Coherus, NASDAQ: CHRS ) and Surface Oncology, Inc. The transaction was unanimously approved by the boards of directors of both companies and is expected to close in the third quarter of 2023. and CAMBRIDGE, Mass., and CAMBRIDGE, Mass.,

article thumbnail

Coherus to Acquire Surface Oncology

Benzinga

June 16, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. Coherus, NASDAQ: CHRS ) and Surface Oncology, Inc. The transaction was unanimously approved by the boards of directors of both companies and is expected to close in the third quarter of 2023. and CAMBRIDGE, Mass., and CAMBRIDGE, Mass.,

article thumbnail

Aprea Therapeutics Announces Acquisition of Atrin Pharmaceuticals Inc. and Reports First Quarter 2022 Financial Results

Benzinga

BOSTON, May 16, 2022 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. NASDAQ: APRE ), a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics targeting DNA damage response pathways today announced that it has acquired Atrin Pharmaceuticals Inc. About Aprea Therapeutics, Inc.

Equity 40
article thumbnail

SpaceX Starlink's New In-Flight Connectivity Service, Amazon's NY Workers Reject Union, Celsius Network Faces Several Federal Investigations: Top Stories Wednesday, Oct. 19

Benzinga

senators inspecting antitrust issues are set to hold a hearing on grocery chain Kroger Co's (NYSE: KR ) plan to acquire rival Albertsons Companies Inc (NYSE: ACI ) in a $25 billion deal. Amazon.com Inc (NASDAQ: AMZN ) was handed a fine by a court in Russia for failing to remove proscribed content on Tuesday.